Cargando…
Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy
Despite major advances in cancer treatment, pancreatic cancer is still incurable and the treatment outcomes are limited. The aggressive and therapy-resistant nature of pancreatic cancer warrants the need for novel treatment options for pancreatic cancer management. Drug repurposing is emerging as an...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Gene & Cell Therapy
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527685/ https://www.ncbi.nlm.nih.gov/pubmed/33024816 http://dx.doi.org/10.1016/j.omto.2020.08.019 |